The Patent Finder

Oncogenex Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Oncogenex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Oncogenex Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,493,500Fluorinated pyrimidine analogs and methods of use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 6,982,282Emulsion vehicle for poorly soluble drugs
Formerly held
Term ended
Term ended Sep 24, 2018 · From the USPTO record
Term endedTerm ended Sep 24, 2018From the USPTO record
US 7,030,155Emulsion vehicle for poorly soluble drugs
Formerly held
Lapsed on the fee record
Ended Apr 18, 2018 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2018From the USPTO record
US 6,458,373Emulsion vehicle for poorly soluble drugs
Formerly held
Term ended
Term ended Jan 5, 2018 · From the USPTO record
Term endedTerm ended Jan 5, 2018From the USPTO record
US 6,727,280Method for treating colorectal carcinoma using a taxane/tocopherol formulation
Formerly held
Lapsed on the fee record
Ended Apr 27, 2012 · From the USPTO record
Lapsed on the fee recordEnded Apr 27, 2012From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited